Major bleeding in patients with coronary or peripheral artery disease treated with rivaroxaban plus aspirin

JW Eikelboom, JJ Bosch, SJ Connolly… - Journal of the American …, 2019 - jacc.org
… the effects of the combination of rivaroxaban and aspirin compared with aspirin on sites,
timing, … the combination of rivaroxaban 2.5 mg twice daily and aspirin 100 mg once daily and …

Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease

JW Eikelboom, DL Bhatt, KAA Fox, J Bosch… - Journal of the American …, 2021 - jacc.org
… Our analyses indicate that the combination of rivaroxaban and aspirin compared with
aspirin alone reduced mortality by 18% in patients with chronic CAD or PAD. The reduction in …

Rivaroxaban with or without aspirin in patients with heart failure and chronic coronary or peripheral artery disease: the COMPASS trial

KR Branch, JL Probstfield, JW Eikelboom, J Bosch… - Circulation, 2019 - Am Heart Assoc
… In this context, the results with the combination of rivaroxaban and aspirin may represent a
… the combination of low-dose rivaroxaban and aspirin in patients with HF, but in very different …

Rivaroxaban plus aspirin versus aspirin in relation to vascular risk in the COMPASS trial

SS Anand, JW Eikelboom, L Dyal, J Bosch… - Journal of the American …, 2019 - jacc.org
… in patients receiving rivaroxaban and aspirin. In applying the results of the COMPASS trial,
the ideal candidates to treat with the combination of rivaroxaban and aspirin include patients

Rivaroxaban plus aspirin in patients with vascular disease and renal dysfunction: from the COMPASS trial

KAA Fox, JW Eikelboom, O Shestakovska… - Journal of the American …, 2019 - jacc.org
… of reduced dose anticoagulation (rivaroxaban) in combination with aspirin in the COMPASS
… alone in patients who are in sinus rhythm but at increased vascular risk. As rivaroxaban 5 …

Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: outcomes during the open label …

JW Eikelboom, J Bosch, SJ Connolly… - European Heart …, 2022 - academic.oup.com
… with the combination of rivaroxaban and aspirin during … available rivaroxaban 2.5 mg twice
daily in combination with aspirin 75–… Open-label combination treatment would continue to be …

[HTML][HTML] Rivaroxaban with or without aspirin in stable cardiovascular disease

JW Eikelboom, SJ Connolly, J Bosch… - … England Journal of …, 2017 - Mass Medical Soc
rivaroxaban alone or in combination with aspirin would be more effective than aspirin alone
… in significantly fewer patients in the rivaroxaban-alone group than in the aspirin-alone group, …

Low-dose rivaroxaban plus aspirin in patients with polypharmacy and multimorbidity: an analysis from the COMPASS trial

T Vanassche, P Verhamme, SS Anand… - European Heart …, 2022 - academic.oup.com
… The COMPASS study demonstrated that the combination of aspirin 100 mg once daily
with rivaroxaban 2.5 mg twice daily reduced major cardiovascular events and cardiovascular …

Efficacy and safety of rivaroxaban plus aspirin in women and men with chronic coronary or peripheral artery disease

Y Liang, J Zhu, L Liu, SS Anand… - Cardiovascular …, 2021 - academic.oup.com
combination of rivaroxaban 2.5 mg twice daily and aspirin 100 mg once daily compared with
… However, this still represents 4048 patients, and our results demonstrate the consistency of …

Low-dose rivaroxaban plus aspirin for the prevention of cardiovascular events: an evaluation of COMPASS

VC Bhagirath, JW Eikelboom, SS Anand - Future Cardiology, 2018 - Taylor & Francis
… Although the COMPASS trial established the benefit of combination rivaroxaban and aspirin
over aspirin alone in a broad population of patients with CV disease, some questions remain…